← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1542)
- Reproductive history and progressive multiple sclerosis risk in women. (2020/11/17) ♡
- Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis. (2020/11/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases. (2020/11/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Sclerosis and Serotonin: Potential Therapeutic Applications. (2020/11/02) ♡
- Determinants of unemployment in multiple sclerosis (MS): The role of disease, person-specific factors, and engagement in positive health-related behaviors. (2020/11/01) ♡
- Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study. (2020/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Demographic and clinical characterization of multiple sclerosis in Mexico: The REMEMBer study. (2020/11/01) ♡
- A longitudinal study of symptom botheration in Multiple Sclerosis. (2020/11/01) ♡
- "I Will Respect the Autonomy of My Patient": A Scoping Review of Shared Decision Making in Multiple Sclerosis. (2020/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Bilateral Optic Neuritis: A Rare Presentation of Clinically Isolated Syndrome. (2020/10/24) ♡
- Voice Conversion for Persons with Amyotrophic Lateral Sclerosis. (2020/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis. (2020/10/01) ♡
- [ARCHITECTONICS OF THE NIGHT SLEEP BASED ON ITS POLYSOMNOGRAPHIC CHARACTERISTICS IN PATIENTS WITH MULTIPLE SCLEROSIS]. (2020/10/01) ♡
- Oxidative Stress and Vitamin D as Predictors in Multiple Sclerosis. (2020/10/01) ♡
- Effects of Retinal Transcription Regulation After GB20 Needling Treatment in Retina With Optic Neuritis. (2020/09/29) ♡
- Cognitive Disorders in Patients with Multiple Sclerosis. (2020/09/01) ♡
- Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement. (2020/08/27) ♡
- Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. (2020/08/01) ♡
- Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial. (2020/07/09) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Mindfulness-Based Interventions for the Improvement of Well-Being in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis. (2020/07/01) ♡
- Eating Pattern and Nutritional Risks among People with Multiple Sclerosis Following a Modified Paleolithic Diet. (2020/06/20) ♡
- Adrenergic hyperactivity: a missing link between multiple sclerosis and cardiovascular comorbidities? (2020/06/01) ♡
- Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany. (2020/06/01) ♡
- Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin. (2020/06/01) ♡
- Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update. (2020/06/01) ♡
- Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. (2020/06/01) ♡
- Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain. (2020/05/04) ♡
- Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients. (2020/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases. (2020/05/01) ♡
- Structural Neural Correlates of Impaired Postural Control in People with Secondary Progressive Multiple Sclerosis. (2020/05/01) ♡
- Patient Satisfaction with Physicians and Nurse Practitioners in Multiple Sclerosis Centers. (2020/05/01) ♡
- Prevalence of dysphagia in a consecutive cohort of subjects with MS using fibre-optic endoscopy. (2020/05/01) ♡
- Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism. (2020/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Species differences in immune-mediated CNS tissue injury and repair: A (neuro)inflammatory topic. (2020/04/01) ♡
- Role of NR3C1 and GAS5 genes polymorphisms in multiple sclerosis. (2020/04/01) ♡
- Disease activity impacts disability progression in primary progressive multiple sclerosis. (2020/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Tumefactive rebound of multiple sclerosis after the short-term cessation of fingolimod: A case report. (2020/04/01) ♡
- Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab. (2020/04/01) ♡
- The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis. (2020/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism. (2020/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment. (2020/04/01) ♡
- The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis. (2020/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats. (2020/03/16) ♡
- Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study. (2020/03/15) ♡
- Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients. (2020/03/14) ♡
- FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models. (2020/03/01) ♡
- A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. (2020/03/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review. (2020/03/01) ♡
- MAIT cell subtypes in multiple sclerosis. (2020/02/15) ♡
- Consensus recommendations on the management of multiple sclerosis patients in Argentina. (2020/02/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.